Chris Markoch

Chris Markoch

Chris Markoch is a freelance financial writer who brings over 25 years in sales and marketing to help find the story behind the stock. Chris starts by asking the question, “So what?” and then uses fundamental and (some) technical analysis to add depth to that insight.

Stepping back from the “what” allows Chris to bring perspective that helps investors make wise decisions based on their risk tolerance and investing timeline.

Markoch would describe his writing as being for investors more than traders. He looks at equities through a long-term lens and that is reflected in his writing.

In addition to his articles on InvestorPlace, you can also find Chris’ writing on MarketBeat.com where he has collaborated on the e-book “5 Investing Trends That Will Define the Market in 2022.” You can find Chris on LinkedIn and on Twitter.

Recent Articles

Give Walmart Stock a Break Ahead of Earnings

Despite being widely considered a pandemic winner, there are three reasons why Walmart stock may slow down for the rest of the year.

Be Sure You’re Clearly Seeing What’s Happening at Ocugen

OCGN stock has been a hot penny stock. But no revenue and a lead candidate that is years away, are reminders that Ocugen is still a penny stock.

6 Retail Stocks Racing Against Bankruptcy

Retail stocks were struggling before the coronavirus shut brick-and-mortar locations. Now these retailers are struggling to avoid bankruptcy.

Fastly Has Problems That Are Bigger Than TikTok

FSLY stock is up over 240% as businesses buy its CDN solutions. But this year's perfect storm may be covering up some obstacles to future growth.

Buy Home Depot Stock for Value Now, Growth Later

Home Depot stock is up 25% making it a big winner of the Covid-19 pandemic. But for the second half of 2020 investors should focus on the stock's value.

Carnival Cruise Line Can Wake Me Up in November

Carnival will sail again. However, future revenue forecasts are based on guesses not science. Until that changes, there's little reason to buy CCL stock.

Stay Away from iBio Until It Has More Than a Story

IBIO stock is rewarding investors who bet on its unique approach to a Covid-19 vaccine. But as the field narrows, iBio needs to deliver more than a story.

Chesapeake Energy Is a Bankruptcy Trap

Despite the certainty that Chesapeake stock will be worthless when the company exits bankruptcy, there are still some investors trying to game the stock.

Ayro Investors Should Look to the Cannabis Industry

Ayro is a leader in the low-speed electric vehicle (LSEV) market. AYRO stock has a good story and a solid plan, However, it may have a problem with demand.

There’s Little Reason for Optimism for American Airlines

AAL stock has tracked closely with the other big four airline stocks during the pandemic. But that doesn't make it a buy.